Arkema to Present Latest Solar Photovoltaic Technology

At the 24th Photovoltaic Solar Energy Exhibition held in Hamburg from 21 to 25 September 2009, Arkema presents its latest innovation for the photovoltaics market: Apolhya™ Solar, a nanostructured thermoplastic polymer for the encapsulation of new generation photovoltaic modules. Apolhya™ Solar combines thermo-mechanical properties, adhesiveness, creep resistance, and perfect transparency.

Apolhya™ Solar is part of the Apolhya™ range, a new family of nanostructured polymers developed by Arkema. This thermoplastic is compatible with processes used to manufacture solar panels based on crystalline silicon or thin layers. One key advantage is that its processing requires no curing. This therefore saves time in the production process, while making end-of-life panels very easy to recycle.

Apolhya™ Solar offers an unrivalled set of properties compared to the other thermoplastics suitable for solar panel encapsulation. The nanostructuring of Apolhya™ Solar ensures excellent long-term transparency. Furthermore, thanks to its easy processing, its adhesion properties, its prolonged heat resistance (its creep resistance is excellent up to 120°C), its UV stability and its low permeability, Apolhya™ Solar is highly suitable for « thin-layer » photovoltaic panels, including flexible modules, and particularly for continuous lamination processes.

A wide range of Apolhya™ Solar grades is available based on various melt temperatures, viscosity, transparency and barrier properties, while other grades can be tailored to specific requirements.

More information on www.apolhyasolar.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.